The store will not work correctly when cookies are disabled.
Diallyl-[4-(2,3-dihydro-imidazo[2,1-a]isoquinolin-5-yl)-benzyl]-amine
ID: ALA80647
PubChem CID: 10021121
Max Phase: Preclinical
Molecular Formula: C24H25N3
Molecular Weight: 355.49
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: C=CCN(CC=C)Cc1ccc(C2=Cc3ccccc3C3=NCCN23)cc1
Standard InChI: InChI=1S/C24H25N3/c1-3-14-26(15-4-2)18-19-9-11-20(12-10-19)23-17-21-7-5-6-8-22(21)24-25-13-16-27(23)24/h3-12,17H,1-2,13-16,18H2
Standard InChI Key: WANZUOVFWFGQCV-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
0.6042 -1.4167 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.0875 -1.7167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6375 -0.8292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1250 -0.5042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.4250 -1.4042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0875 -2.3167 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.4083 -0.8000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2375 -0.8292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5292 -1.3500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5292 -0.3167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1250 -1.7167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4417 -0.1292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7125 0.6000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5542 1.1833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0250 -0.2875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1250 -2.3167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4500 -0.4042 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.0292 -0.8292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4292 -0.8292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1250 -0.3125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1292 -1.3500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9583 -1.6792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9208 -0.4792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0250 -0.5542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2875 0.1750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4708 -1.3667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4583 -0.7667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 1 1 0
4 3 2 0
5 2 1 0
6 2 2 0
7 4 1 0
8 3 1 0
9 8 2 0
10 8 1 0
11 1 1 0
12 24 1 0
13 25 1 0
14 13 2 0
15 12 2 0
16 11 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 10 2 0
21 9 1 0
22 5 1 0
23 7 1 0
24 17 1 0
25 17 1 0
26 22 2 0
27 23 2 0
16 6 1 0
7 5 2 0
19 21 2 0
26 27 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 355.49 | Molecular Weight (Monoisotopic): 355.2048 | AlogP: 4.43 | #Rotatable Bonds: 7 |
Polar Surface Area: 18.84 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 8.14 | CX LogP: 4.46 | CX LogD: 3.51 |
Aromatic Rings: 2 | Heavy Atoms: 27 | QED Weighted: 0.68 | Np Likeness Score: -0.66 |
References
1. Houlihan WJ, Munder PG, Handley DA, Cheon SH, Parrino VA.. (1995) Antitumor activity of 5-aryl-2,3-dihydroimidazo[2,1-a]isoquinolines., 38 (2): [PMID:7830265] [10.1021/jm00002a004] |